MATINAS BIOPHARMA HOLDINGS, INC. Earnings Per Share (Basic)
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Earnings Per Share (Basic) of -$0.21 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.21.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.30.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.30.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.40.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic for fiscal 2025 was -$2.00.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic for fiscal 2024 was -$4.98.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic for fiscal 2023 was -$5.28.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic for fiscal 2022 was -$0.10.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.21 10-Q · filed 2026-08-13 | -$0.51 10-Q · filed 2026-08-13 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$0.30 10-Q · filed 2026-05-08 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$0.99 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$1.93 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.66 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.00 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$0.40 10-Q · filed 2025-11-10 | -$1.41 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.74 10-Q · filed 2025-11-10 | -$3.38 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$1.03 10-Q · filed 2026-08-13 | -$1.36 10-Q · filed 2026-08-13 | -$3.01 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$3.86 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-03-31 | -$0.33 10-Q · filed 2026-05-08 | -$1.98 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$2.83 derived: net income ÷ weighted average shares · filed 2026-05-08 | |||||
| 2024-12-31 | -$1.66 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.51 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$4.98 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | -$0.85 10-Q · filed 2025-11-10 | -$3.30 10-Q · filed 2025-11-10 | ||||||
| 2024-06-30 | -$1.15 10-Q · filed 2025-08-14 | -$0.02 10-Q · filed 2024-08-14 | -$2.47 10-Q · filed 2025-08-14 | -$0.05 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | -$1.34 10-Q · filed 2025-05-15 | -$0.03 10-Q · filed 2024-05-09 | ||||||
| 2023-12-31 | -$5.28 10-K · filed 2025-04-15 | -$0.11 10-K · filed 2024-03-27 | ||||||
| 2023-09-30 | -$1.39 10-Q · filed 2024-11-13 | -$0.03 10-Q · filed 2023-11-08 | -$4.06 10-Q · filed 2024-11-13 | -$0.08 10-Q · filed 2023-11-08 | ||||
| 2023-06-30 | -$0.03 10-Q · filed 2024-08-14 | -$0.05 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$0.03 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$0.04 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$0.07 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$0.10 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -$0.03 10-Q · filed 2023-11-08 | -$0.05 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.08 10-Q · filed 2023-11-08 | -$0.11 derived: net income ÷ weighted average shares · filed 2023-11-08 | ||||
| 2022-06-30 | -$0.03 10-Q · filed 2023-08-09 | -$0.06 10-Q · filed 2023-08-09 | -$0.05 10-Q · filed 2022-08-11 | -$0.09 derived: net income ÷ weighted average shares · filed 2023-08-09 | -$0.12 derived: net income ÷ weighted average shares · filed 2023-08-09 | |||
| 2022-03-31 | -$0.03 10-Q · filed 2023-05-10 | -$0.06 derived: net income ÷ weighted average shares · filed 2023-05-10 | -$0.09 derived: net income ÷ weighted average shares · filed 2023-05-10 | -$0.11 derived: net income ÷ weighted average shares · filed 2023-05-10 | ||||
| 2021-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.06 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.09 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.11 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | -$0.03 10-Q · filed 2022-11-02 | -$0.06 derived: net income ÷ weighted average shares · filed 2022-11-02 | -$0.08 10-Q · filed 2022-11-02 | |||||
| 2021-06-30 | -$0.02 10-Q · filed 2022-08-11 | -$0.05 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | -$0.03 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |